563088 78 witschi a reddy s stofer b lauterburg b h the systemic availability of oral glutathione european journal of clinical pharmacology 1992 43 6 667 9 cited in pubmed 1362956 79 ozols r f pharmacologic reversal of drug resistance in ovarian cancer seminars in oncology 1985 12 3 suppl 4 7 11 cited in pubmed 4048979 80 chen h h kuo m t role of glutathione in the regulation of cisplatin resistance in cancer chemotherapy metal based drugs 2010 2010 cited in pubmed 20885916 http www ncbi nlm nih gov pmc articles pmc2946579 tool pubmed 81 zhou s f structure function and regulation of p glycoprotein and its clinical relevance in drug disposition xenobiotica the fate of foreign compounds in biological systems 2008 38 7 8 802 32 cited in pubmed 18668431 82 buda g ricci d huang c c favis r cohen n zhuang s h et al polymorphisms in the multiple drug resistance protein 1 and in p glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin annals of hematology 2010 89 11 1133 40 cited in pubmed 20532504 http www ncbi nlm nih gov pmc articles pmc2940014 tool pubmed 83 acs insulin potentiated therapy cancer treatment information serial on the internet 2010 american cancer society available from http www cancer org treatment treatmentsandsideeffects complementaryandalternativemedi cine pharmacologicalandbiologicaltreatment insulin potentiation therapy 84 bump e a yu n y brown j m radiosensitization of hypoxic tumor cells by depletion of intracellular glutathione science new york n y 1982 217 4559 544 5 cited in pubmed 7089580 85 hiraiwa.